The once-weekly injectable has been dubbed 'triple g' because it targets three different hormones, compared to Ozempic and Wegovy which target one, and Eli Lilly's other weight-loss drug Mounjaro, which targets two hormones
NAD IV therapy plays a key role in boosting the effectiveness of peptide therapy by replenishing essential coenzymes involved in cellular energy production and DNA repair
For instance, the multidisciplinary expert consensus available at MDPI provides a comprehensive guide to manage gastrointestinal side effects that patients may encounter
Consistent with FDA labeling, GLP-1 RAs amplify hypoglycemia risk when combined with insulin or sulfonylureas 42 , a complication linked to seizures, syncope, and tremors 43
The Lancet Diabetes & Endocrinology , 6(12), 981990